NEWARK, Del, March 04, 2024 (GLOBE NEWSWIRE) -- Future Market Insights anticipated that the global needle-free injection systems market size is going to reach US$ 667 million by 2034, up from US$ 158 million in 2024. Between 2024 and 2034, the market is projected to rise at a startling 15.5% compound annual growth rate. The global sales of needle-free injection systems are expected to surge owing to the growing emphasis on advanced and effective treatment approaches. This trend highlights the increasing demand for innovative medical technologies that offer a painless and efficient alternative to traditional injections. As such, the market for needle-free injection systems is anticipated to witness substantial growth in the upcoming decade.
The current global market for needle-free injection systems is experiencing significant growth, primarily driven by the rising demand for painless drug delivery methods, advancements in healthcare technology, and the expanding range of applications across various medical fields. This growth trend is expected to continue in the foreseeable future. The increasing interest in needle-free injection systems is primarily due to their potential to minimize the pain, discomfort, and anxiety associated with traditional needle-based injections.
Request A Sample Copy of This Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-19014
Needle-free injection systems offer several other advantages, such as reducing the risk of needlestick injuries and eliminating the need for sharps disposal, making them a safer and more convenient alternative to traditional injection methods. These advantages have increased the interest and demand for needle-free injection systems across various medical fields, including diabetes management, vaccine administration, and pain management. The market for needle-free injection systems is poised for significant expansion, with numerous opportunities for market players to capitalize on such a growing trend.
The growing need for drug delivery methods that are both painless and convenient is propelling the development of needle-free systems. As a result, the adoption of needle-free drug delivery devices is on the rise. These innovative prospects offer patients a more comfortable and less invasive option for receiving medication, making them an attractive alternative to traditional needle-based delivery methods.
The future of injections is looking sharp-free! The needle-free injection system market is poised for significant growth, driven by increasing regulatory approvals and the growing popularity of self-administered medications. This shift towards needle-free delivery promises a safer and more comfortable experience for patients, eliminating the risk of infection and needle-related anxieties. As these innovative solutions gain traction, we can expect a surge in demand for needle-free injectors throughout the coming decade.
“The adoption of needle-free drug delivery devices is on the rise, driven by the need for painless and convenient medication administration. These innovative prospects offer patients a more comfortable and less invasive option for receiving medication while reducing the risk of infections and needlestick injuries. The future of drug delivery is looking brighter with the advancements in technology and the growing demand for patient-centric solutions.” - opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).
Key Takeaways from the Needle-Free Injection System Market:
- The United States needle-free injection system industry is projected to experience a CAGR of 15.1% through 2034.
- Japan’s needle-free injection system market is expected to demonstrate a rapid CAGR of 17.1% through 2034.
- The United Kingdom’s needle-free injection system industry is anticipated to see a CAGR of 16.5% through 2034.
- South Korea’s needle-free injection system industry showcases a significant CAGR of 12.8% through 2034.
- China’s needle-free injection system market is expected to display a favorable CAGR of 16.3% through 2034.
Act Now to Explore In-Depth Market Analysis: Purchase Now to Access Market Insights: https://www.futuremarketinsights.com/checkout/19014
Competitive Landscape of the Needle-Free Injection System Market:
Research organizations such as Medical International Technology are expected to promote innovation by consistently enhancing delivery methods, usability, and safety features. The establishment of policies and regulations to guarantee the security, effectiveness, and caliber of needle-free injection devices is going to be mostly the responsibility of regulatory bodies.
The integration of needle-free systems into medical procedures by healthcare practitioners is expected to increase their utilization and stimulate market demand. Pharma Jet and Antares Pharma, pharmaceutical firms, are working with device makers to develop and market needle-free administration systems for various drugs. Technology companies that integrate AI, such as Bioject Medical Technologies, are anticipated to drive industry breakthroughs through connection and integration.
Recent Developments in the Needle-Free Injection System Market:
- Pulse NeedleFree Systems introduced the world's first disposable line of needle-free livestock vaccination devices in August 2023, offering health and food safety benefits to pork producers at a cost comparable to conventional syringes and needles.
- The precision delivery system provider PharmaJet obtained encouraging results in September 2023 from Scancell's Phase 2 clinical trial about using the PharmaJet Stratis System, a patient-preferred needle-free injection technique, to treat patients with incurable metastatic melanoma.
Key Companies in the Needle-Free Injection System Market:
- Pharma Jet (United States)
- Antares Pharma. (United States)
- Medical International Technology, Inc. (MIT United States)
- Bioject Medical Technologies (United States)
- Portal Instruments (United States)
- Zogenix (United States)
- Crossject (France)
- Inovio Pharmaceuticals, Inc. (United States)
- National Medical Products (China)
- Endo International plc (Ireland)
Request Report Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-19014
Key Segments:
By Product:
- Prefilled needle-free injectors
- Fillable needle-free injectors
By Type:
- Liquid-based needle-free injectors
- Powder-based needle-free injectors
- Projectile/depot-based needle-free injectors
By Technology:
- Jet-based needle-free injectors
- Spring-based needle-free injectors
- Micro array patch injectors
- Others
By Site of Delivery:
- Intra-dermal injectors
- Intramuscular injectors
- Subcutaneous injectors
By Usability:
- Disposable needle-free injectors
- Reusable needle-free injectors
By Application:
- Vaccine Delivery
- Insulin delivery
- Pain management
- Others
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s related ongoing Coverage in the Healthcare Market Insights Domain:
Injectable Drug Delivery Market Size: The injectable drug delivery market is expected to expand its roots with a steady CAGR of 8.9% during the forecast period. The market holds a share of US$ 45.3 Billion in 2023 while expecting revenue of US$ 106.4 Billion by 2033.
Non-injectable Insulin Market Share: The non-injectable insulin market is projected to generate US$ 1,372.9 million in 2024. non-injectable insulin market revenue is predicted to reach US$ 4,418.70 million by 2034. A CAGR of 9.50% is expected for the non-injectable insulin market during the forecast period.
Knee Hyaluronic Acid Injections Market Demand: The knee hyaluronic acid injections market revenue totaled US$ 2.09 billion in 2023, according to the latest insights by the Future Market Insights survey. The overall sales of knee hyaluronic acid injections are expected to reach US$ 3.40 billion, with growth at a CAGR of 5% by 2033.
Injection Pen Market Trends: The global injection pen market is forecasted to expand at 7.0% CAGR to reach a market valuation of US$ 85.8 billion by the end of 2033, up from US$ 43.4 billion that was recorded for 2023.
Intradermal Injection Market Outlook: The global intradermal injection market is expected to surpass an impressive valuation of US$ 3,878 Million in 2022 and is projected to exhibit a compound annual growth rate (CAGR) of 10.8% from 2022 to 2032.
Submucosal Injections Market Overview: The submucosal injections market is estimated to secure a valuation of US$ 1.3 Billion in 2023 and is estimated to rise to US$ 2.3 Billion by 2033. The market is anticipated at a CAGR of 5.8% during the forecast period.
Needle-Free Injectors Market Growth: Global demand for Needle-Free Injectors is expected to rise at a yearly growth rate of 12% Y-o-Y to US$ 42.79 Billion in 2032
Ultrasound Market Development: The ultrasound market is set to be valued at US$ 11.70 billion in 2024 and is projected to reach US$ 20.40 billion by 2034, exhibiting a modest CAGR of 5.80% over the forecast period.
Synthetic Biology Market Opportunity: The synthetic biology market is expected to rise from US$ 3.75 billion in 2024 to US$ 31.73 billion by 2034, growing at a lucrative 23.8% CAGR over the forecast period.
Cardiology Information System Market Forecast: The cardiology information system market is estimated to be valued at US$ 1.3 billion in 2024. The cardiology information system is predicted to rise at a CAGR of 9.7% from 2024 to 2034. The global cardiology information system market is anticipated to reach US$ 3.7 billion by 2034.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
